Compare AbCellera Biologics Inc (ABCL) vs American Financial Group Inc (AFG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs American Financial Group Inc — how do they compare? AbCellera Biologics Inc trades at $9.19 (market cap $2.99B), while American Financial Group Inc trades at $144.65 (market cap $11.97B). The key difference: American Financial Group Inc is far larger — about 4× AbCellera Biologics Inc's market cap, and American Financial Group Inc pays a 2.44% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AFG | |
|---|---|---|
Market Cap | $2.99B | $11.97B |
Sector | Health | Financials |
52-Week High | $9.76 | $148.71 |
52-Week Low | $2.78 | $124.18 |
Enterprise Value | $2.58B | $12.35B |
Dividend Yield | — | 2.44% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About American Financial Group Inc
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →
